Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Today, over 55 million people in the U.S
Tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for weight management, is a dual GIP and GLP-1 receptor agonist that has transformed metabolic treatment
It is a drug part of the glucagon-like-peptide 1 receptor antagonists, or GLP-1 receptor antagonist family, that when specifically used for treating weight loss, acts on GLP-1 receptors in the brain, on top of the liver, pancreas, and stomach
Choosing the Best Day of the Week The day of the week you choose is often more impactful than the time of day
Where things stand (June 2026) CagriSema Phase 3 results have been reported
US$ 27.57
US$ 23.10
US$ 22.10
US$ 21.78
